Skip to main content

Advertisement

SpringerLink
Log in

Metabolic Syndrome: A Construct with Limited Relevance to Children

  • Pediatrics (S Gidding, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

The prevalence of obesity in youth has increased dramatically over the last 3 decades. Similar to adults, obese children often display clusterings of risk factors associated with heightened risk for future cardiovascular disease. In adults, this clustering is commonly referred to as the metabolic syndrome and is used to identify individuals at high risk for premature cardiovascular disease and diabetes. Conversely, the relevance of a pediatric metabolic syndrome diagnosis to predict future adult cardiovascular outcomes is less clear. Many pediatric definitions of the metabolic syndrome have been proposed, yet no consensus has been adopted due to inconsistent study results, lack of translational relevance of childhood classifications to future disease, and instability of the criteria used for various definitions. Given absence of substantial evidence for using a dichotomous metabolic syndrome diagnosis over individual cardiometabolic risk factors, clinicians and experts must proceed with caution when diagnosing metabolic syndrome to guide treatments recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1:11–25.

    Article  PubMed  Google Scholar 

  2. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806–14.

    Article  PubMed  CAS  Google Scholar 

  3. Guo SS, Chumlea WC. Tracking of body mass index in children in relation to overweight in adulthood. Am J Clin Nutr. 1999;70:S145–8.

    Google Scholar 

  4. Freedman DS, Khan LK, Dietz WH, et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics. 2001;108:712–8.

    Article  PubMed  CAS  Google Scholar 

  5. Freedman DS, Kettel L, Serdula MK, et al. The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics. 2005;115:22–7.

    PubMed  Google Scholar 

  6. Freedman D, Wang J, Thornton JC, et al. Classification of body fatness by body mass index-for-age categories among children. Arch Pediatr Adolesc Med. 2009;163:801–11.

    Google Scholar 

  7. Grundy SM. Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol. 2005;25:2243–4.

    Article  PubMed  CAS  Google Scholar 

  8. Smoak CG, Burke GL, Webber LS, et al. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol. 1987;125:364–72.

    PubMed  CAS  Google Scholar 

  9. Chen W, Bao W, Begum S, et al. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes. 2000;49:1042–8.

    Article  PubMed  CAS  Google Scholar 

  10. Meigs JB, D’Agostino Sr RB, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46:1594–600.

    Article  PubMed  CAS  Google Scholar 

  11. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715–22.

    Article  PubMed  CAS  Google Scholar 

  12. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

    Article  PubMed  CAS  Google Scholar 

  13. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism. 1996;45:699–706.

    Article  PubMed  CAS  Google Scholar 

  14. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–31.

    Article  PubMed  CAS  Google Scholar 

  15. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514–20.

    Article  PubMed  CAS  Google Scholar 

  16. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–94.

    Article  PubMed  CAS  Google Scholar 

  17. Hu G, Qiao Q, Tuomilehto J, et al. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. The DECODE Insulin Study Group. Diabetologia. 2004;47:1245–56.

    PubMed  CAS  Google Scholar 

  18. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087–94.

    Article  PubMed  CAS  Google Scholar 

  19. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.

    Article  PubMed  CAS  Google Scholar 

  20. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of non-insulin-dependent diabetes in women: the Nurses’ Health Study. Am J Epidemiol. 1997;145:614–9.

    Article  PubMed  CAS  Google Scholar 

  21. Lee IM, Manson JE, Hennekens CH, et al. Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA. 1993;270:2823–8.

    Article  PubMed  CAS  Google Scholar 

  22. Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–8.

    Article  PubMed  CAS  Google Scholar 

  23. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055–8.

    Article  PubMed  CAS  Google Scholar 

  24. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843–8.

    Article  PubMed  CAS  Google Scholar 

  25. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733–9.

    Article  PubMed  CAS  Google Scholar 

  26. Anderson PJ, Critchley JA, Chan JC, et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes. 2001;25:1782.

    Article  CAS  Google Scholar 

  27. Hu G, Qiao Q, Tuomilehto J, et al. The DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066–76.

    Article  PubMed  Google Scholar 

  28. Balkau B, Charles MA. Comments on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance. Diabet Med. 1999;16:442–3.

    Article  PubMed  CAS  Google Scholar 

  29. National Institutes of Health. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III Final Report). Bethesda: National Institutes of Health; 2002.

    Google Scholar 

  30. World Health Organization, Department of Noncommunicable Disease Surveillance. Report of a WHO Consultation: Definition of Metabolic Syndrome in Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999.

  31. Chen W, Srinivasan SR, Elkasabany A, et al. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999;150:667–74.

    Article  PubMed  CAS  Google Scholar 

  32. Raitakari OT, Porkka KV, Rönnemaa T, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents: the Cardiovascular Risk in Young Finns Study. Diabetologia. 1995;38:1042–50.

    Article  PubMed  CAS  Google Scholar 

  33. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818–25.

    Article  PubMed  CAS  Google Scholar 

  34. Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160–7.

    Article  PubMed  CAS  Google Scholar 

  35. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.

    Article  PubMed  Google Scholar 

  36. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

    Article  Google Scholar 

  37. Hanson RL, Imperatore G, Bennett PH, et al. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes. 2002;51:3120–7.

    Article  PubMed  CAS  Google Scholar 

  38. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51:931–8.

    Article  PubMed  CAS  Google Scholar 

  39. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.

    Article  PubMed  CAS  Google Scholar 

  40. Grundy SM, Hansen B, Smith Jr SC, et al. For conference participants. Clinical Management of Metabolic Syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management. Circulation. 2004;109:551–6.

    Article  PubMed  Google Scholar 

  41. Smith SR. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk. Obesity. 2006;14:128S–34S.

    Article  PubMed  Google Scholar 

  42. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628–47.

    Article  PubMed  Google Scholar 

  43. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003;157:821–7.

    Article  PubMed  Google Scholar 

  44. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999–2000. Diabetes Care. 2004;27:2438–43.

    Article  PubMed  Google Scholar 

  45. Goodman E, Daniels SR, Morrison JA, et al. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145:445–51.

    Article  PubMed  Google Scholar 

  46. Lambert M, Paradis G, O’Loughlin J, et al. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833–41.

    Article  PubMed  CAS  Google Scholar 

  47. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–74.

    Article  PubMed  CAS  Google Scholar 

  48. Srinivasan SR, Bao W, Wattigney WA, et al. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism. 1996;45:235–40.

    Article  PubMed  CAS  Google Scholar 

  49. Freedman DS, Dietz WH, Srinivasan SR, et al. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103(Pt 1):1175–82.

    Article  PubMed  CAS  Google Scholar 

  50. Raitakari OT, Porkka KV, Viikari JS, et al. Clustering of risk factors for coronary heart disease in children and adolescents: the Cardiovascular Risk in Young Finns Study. Acta Paediatr. 1994;83:935–40.

    Article  PubMed  CAS  Google Scholar 

  51. Katzmarzyk PT, Srinivasan SR, Chen W, et al. Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics. 2004;114:e198–205.

    Article  PubMed  Google Scholar 

  52. Morrison JA, Sprecher DL, Barton BA, et al. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr. 1999;135:458–64.

    Article  PubMed  CAS  Google Scholar 

  53. Golley RK, Magarey AM, Steinbeck KS, et al. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes (Lond). 2006;30:835–60.

    Article  Google Scholar 

  54. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diabetes Rep. 2004;4:53–62.

    Article  Google Scholar 

  55. de Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–7.

    Article  PubMed  Google Scholar 

  56. Chu NF, Rimm EB, Wang DJ, et al. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr. 1998;67:1141–6.

    PubMed  CAS  Google Scholar 

  57. Rodríguez-Morán M, Salazar-Vázquez B, Violante R, et al. Metabolic syndrome among children and adolescents aged 10–18 years. Diabetes Care. 2004;27:2516–7.

    Article  PubMed  Google Scholar 

  58. Huang TT, Nansel TR, Belsheim AR, et al. Sensitivity, specificity, and predictive values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: the Princeton LRC follow-up study. J Pediatr. 2008;152:185–90.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Goodman E, Daniels SR, Meigs JB, et al. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation. 2007;115:2316–22.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Gustafson JK, Yanoff LB, Easter BD, et al. The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab. 2009;94:4828–34.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  61. Magnussen CG, Koskinen J, Chen W, et al. Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation. 2010;122:1604–11.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Schubert CM, Sun SS, Burns TL, et al. Predictive ability of childhood metabolic components for adult metabolic syndrome and type 2 diabetes. J Pediatr. 2009;155:S6.e1–7.

    Article  Google Scholar 

  63. Schubert CM, Cook S, Sun SS, et al. Additive utility of family history and waist circumference to body mass index in childhood for predicting metabolic syndrome in adulthood. J Pediatr. 2009;155:S6.e9–13.

    Google Scholar 

  64. Kelly AS, Steinberger J, Jacobs DR, et al. Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood. Int J Pediatr Obes. 2011;6:e283–9. This study reported that a metabolic syndrome ‘cluster score’ was more reliable in predicting young adult risk from late childhood metabolic syndrome compared with a dichotomous metabolic syndrome diagnosis. The cluster score was derived using components of the metabolic syndrome as a continuous variable.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Winjndaele K, Beunen G, Duvigneaud N, et al. A continuous metabolic syndrome risk score: utility for epidemiological analyses. Diabetes Care. 2006;29:2329.

    Article  Google Scholar 

  66. Amiel SA, Sherwin RS, Simonson DC, et al. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986;315:215–9.

    Article  PubMed  CAS  Google Scholar 

  67. Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr. 1987;110:481–7.

    Article  PubMed  CAS  Google Scholar 

  68. Caprio S, Plewe G, Diamond M, et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr. 1989;114:963–7.

    Article  PubMed  CAS  Google Scholar 

  69. Moran A, Jacobs Jr DR, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039–44.

    Article  PubMed  CAS  Google Scholar 

  70. Batey LS, Goff Jr DC, Tortolero SR, et al. Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: the Corpus Christi Child Heart Study. Circulation. 1997;96:4319–25.

    Article  PubMed  CAS  Google Scholar 

  71. Arslanian S, Suprasongsin C, Janosky JE. Insulin secretion and sensitivity in black versus white prepubertal healthy children. J Clin Endocrinol Metab. 1997;82:1923–7.

    PubMed  CAS  Google Scholar 

  72. Svec F, Nastasi K, Hilton C, et al. Black-white contrasts in insulin levels during pubertal development: the Bogalusa Heart Study. Diabetes. 1992;41:313–7.

    Article  PubMed  CAS  Google Scholar 

  73. Arslanian S, Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents. J Pediatr. 1996;129:440–3.

    Article  PubMed  CAS  Google Scholar 

  74. Freedman DS, Patel DA, Srinivasan SR, et al. The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study. Int J Obes (Lond). 2008;32:749–56.

    Article  CAS  Google Scholar 

  75. Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:2277–83.

    Article  PubMed  CAS  Google Scholar 

  76. Burns TL, Letuchy EM, Paulos R, et al. Childhood predictors of the metabolic syndrome in middle-aged adults: the Muscatine study. J Pediatr. 2009;155:S5–S26.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213–56. This expert panel summary report details cardiovascular health and risk reduction in youth and highlights the use of standard levels of common cardiovascular risk factors in defining such risks based on population-based distributions previously defined rather than levels based on longitudinal examination.

  78. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl):555–76.

  79. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2002;246:1–190.

    PubMed  Google Scholar 

  80. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120 Suppl 4:S164–92.

    Article  PubMed  Google Scholar 

  81. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3 Pt 2):525–84.

    Google Scholar 

  82. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381–9.

  83. Freedman DS, Khan LK, Serdula MK, et al. Racial differences in the tracking of childhood BMI to adulthood. Obes Res. 2005;13:928–35.

    Article  PubMed  Google Scholar 

  84. Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365:1876–85. This study reported the risks of type 2 diabetes, hypertension, dyslipidemia, and carotid-artery atherosclerosis among overweight or obese children who became non-obese by adulthood were similar to those among persons who were never obese. BMI was used to classify children as overweight or obese.

    Article  PubMed  CAS  Google Scholar 

  85. Bayer O, Kruger H, von Kries R, Toschke AM. Factors associated with tracking of BMI: a meta-regression analysis on BMI tracking. Obesity (Silver Spring). 2011;19:1069–76. This meta-regression analysis reported BMI at first measurement had no influence on BMI tracking into adulthood, and was observed as similar to obese, under-, or normal-weight individuals. Blood pressure demonstrated reduced tracking compared with BMI.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Kara Marlatt declares that she has no conflicts of interest. Julia Steinberger received grants from the NIH.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. School of Kinesiology, University of Minnesota, Minneapolis, MN, 55455, USA

    Kara L. Marlatt

  2. Department of Pediatrics, Division of Cardiology, University of Minnesota Amplatz Children’s Hospital, East Building Room MB559, 2450 Riverside Avenue, Minneapolis, MN, 55455, USA

    Julia Steinberger

Authors
  1. Kara L. Marlatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julia Steinberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julia Steinberger.

Additional information

This article is part of the Topical Collection on Pediatrics

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marlatt, K.L., Steinberger, J. Metabolic Syndrome: A Construct with Limited Relevance to Children. Curr Cardiovasc Risk Rep 8, 402 (2014). https://doi.org/10.1007/s12170-014-0402-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-014-0402-9

Keywords

Search

Navigation